Agios Pharmaceuticals | هزینه بهره بدهی



Interest Expense On Debt تغییر دادن تاریخ
AbbVie USD 700M 90M 2025-03
Agios Pharmaceuticals 3.01M 10.05M 2024-12
Alnylam Pharmaceuticals USD 40.25M 1.6M 2025-06
Amgen USD 694M 29M 2025-06
Arrowhead Research USD 24.38M 2.74M 2025-06
Astellas Pharma 3.91B 320M 2025-03
AstraZeneca 303M 126M 2025-06
Bayer 495M 89M 2025-06
Biogen USD 72.6M 12.6M 2025-06
BioMarin Pharmaceutical USD 2.68M 184K 2025-06
Bristol-Myers Squibb USD 485M 9M 2025-06
Daiichi Sankyo 1.42B 5.66B 2025-06
Eli Lilly USD 249M 5.3M 2025-06
Exelixis 23.4M 3.9M 2023-09
Gilead Sciences USD 254M 6M 2025-06
GlaxoSmithKline 184M 22M 2025-06
Incyte USD 594K 66K 2025-06
Ionis Pharmaceuticals USD 19M 0 2025-06
Merck USD 305M 8M 2025-06
Moderna USD 1000K 0 2025-06
Novartis USD 289M 19M 2025-06
Novartis USD 275M 11M 2024-12
Pfizer USD 654M 0 2025-06
Regeneron Pharmaceuticals USD 3.6M 5.1M 2025-06
Roche Holding CHF 311.5M 1000K 2024-12
Sarepta Therapeutics USD 5.23M 725K 2025-06
Vertex Pharmaceuticals USD 3.7M 900K 2025-06


Agios Pharmaceuticals هزینه بهره بدهی - ارزش های فعلی، داده های تاریخی، پیش بینی، آمار، نمودار و تقویم اقتصادی - Aug 2025.